Sanofi Looks to Second-Generation Emerging Markets with Genfar Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 10 (Table of Contents)
Published: 24 Oct-2012
DOI: 10.3833/pdr.v2012.i10.1823 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Only weeks after declaring that it was seeking deal opportunities in second-generation emerging markets such as Vietnam, Indonesia and Colombia, Sanofi has agreed to acquire Genfar, the second-largest generics company in Colombia in terms of sales...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018